The Lind Scurvy Trial: The First Controlled Clinical Trial

On May 20, 1747, a Scottish naval surgeon assigned to HMS Salisbury did something that had never been done systematically in the history of medicine: he took 12 patients with the same condition, matched them for severity, kept their background diets identical, and gave different treatments to different pairs — then watched what happened. James Lind's six-pair test of scurvy remedies was not just an experiment about citrus fruit. It was the birth of the controlled clinical trial, the method by which medicine eventually learned to tell the difference between treatments that work and those that merely seem to.

What Scurvy Was Doing to Navies

Scurvy killed sailors in numbers that dwarfed combat losses. The disease results from a deficiency of ascorbic acid (vitamin C), which the human body cannot synthesize and must obtain entirely through diet. On long ocean voyages — before refrigeration, before reliable fresh food supplies — crews ran out of vitamin C within weeks.

Scurvy — a disease caused by severe deficiency of ascorbic acid (vitamin C), characterized by weakening of connective tissue throughout the body. Vitamin C is required for the synthesis of collagen, the structural protein that holds blood vessels, skin, cartilage, and scar tissue together.

The symptoms progress in a way that reflects the collapse of connective tissue from the inside out. First come fatigue, irritability, and aching joints — easily attributed to hard work and poor weather. Then the gums swell, turn spongy, and begin to bleed. Old healed wounds reopen as collagen degrades and the scar tissue dissolves. Teeth loosen and fall out. Skin hemorrhages appear spontaneously. Without treatment, death follows from internal bleeding or organ failure, typically within months of the deficiency beginning.

Source: Carpenter, K. J. (1986), The History of Scurvy and Vitamin C, Cambridge University Press — comprehensive history of scurvy's epidemiology and the road to ascorbic acid isolation.

During Anson's circumnavigation of the globe from 1740 to 1744 — just three years before Lind's experiment — 1,051 of the original 1,854 men who set out with the squadron died, the vast majority from scurvy. Anson completed the voyage with fewer than 500 men.

Source: Williams, G. (1999), The Prize of All the Oceans: Commodore Anson's Voyage Round the World, Viking — account of Anson's expedition losses, primarily from scurvy.

The scale of the problem was not a secret. Naval commanders, physicians, and government officials all knew that long ocean voyages produced catastrophic disease losses. What no one knew — despite dozens of competing theories — was what caused scurvy or how to prevent it reliably.

Why the Cause Was So Difficult to Identify

The scientific problem was genuine, and understanding why it was hard to solve explains why Lind's experiment mattered structurally, not just nutritionally.

Scurvy had been observed for centuries, and dozens of remedies had been proposed and claimed to work: citrus fruits, cider, vinegar, spruce beer, fresh vegetables, fresh meat, malt extract, seawater, and combinations of all of these. Practitioners reported success with almost every one of them under some circumstances.

The reason is straightforward in retrospect. Any remedy that provided even small amounts of vitamin C — which includes cider, malt extract, and some preparations of vegetables — would produce partial recovery in mildly affected patients. Any voyage that encountered fresh food at a port of call would see crew health improve, regardless of what was being issued as a "treatment." The signal was buried in noise, and without a systematic method for isolating variables, no one could identify which specific element in which food was doing the work.

By the 1740s, approximately twelve distinct theories of scurvy's cause existed simultaneously, each supported by anecdotal clinical evidence. They included acidity in the blood, putrefaction of food in the stomach, obstruction of perspiration, excessive salt in the diet, and lack of fresh air.

Source: Bown, S. R. (2003), Scurvy: How a Surgeon, a Mariner and a Gentleman Solved the Greatest Medical Mystery of the Age of Sail, Thomas Dunne Books — account of competing theories and the state of scurvy understanding in 1747.

Lind did not know the cause either. What he did know was that he could not make progress by reading case reports and drawing conclusions. He needed to compare treatments directly, in the same patients, under the same conditions, at the same time.

James Lind: Surgeon, Empiricist

James Lind was born in Edinburgh in 1716 and trained as a surgeon's apprentice before joining the Royal Navy as a surgeon's mate in 1739. He served in the Mediterranean, West Africa, and the English Channel before being posted to HMS Salisbury in 1747.

He was not a physician in the formal sense — surgeons occupied a lower social rank than physicians in eighteenth-century medicine, dealing with wounds and physical ailments rather than with "physic" (internal medicine). But he was empirically minded, methodologically rigorous, and deeply skeptical of received wisdom.

Source: Milne, I. (2012), "Who was James Lind, and what exactly did he achieve?", James Lind Library — biographical review of Lind's naval career and scientific approach.

Lind left the navy in 1748, completed a medical degree at Edinburgh in 1748, and in 1753 published A Treatise of the Scurvy, the document that formalized his 1747 experiment. He spent the rest of his career at Haslar Naval Hospital, near Portsmouth, eventually becoming its physician-in-chief. He died in 1794.

The Experiment on HMS Salisbury

By May 1747, HMS Salisbury had been at sea long enough that scurvy had taken hold of a significant portion of the crew. Lind selected 12 men with similar presentations — similar symptoms, similar severity, similar general condition. This was a methodological choice that he explicitly described: he wanted to start with subjects as alike as possible so that differences in outcome could be attributed to differences in treatment rather than differences in baseline health.

He housed all 12 men in the same space, gave them all the same basic diet — a common shipboard ration — and then divided them into six pairs. Each pair received a different supplement on top of the common diet:

Pair	Treatment
1	One quart of cider daily
2	25 drops of elixir vitriol (dilute sulfuric acid) three times daily
3	Six spoonfuls of vinegar three times daily
4	Half a pint of seawater daily
5	Two oranges and one lemon daily
6	A paste of garlic, mustard seed, horseradish, balsam of Peru, and myrrh

The citrus supply ran out after six days. In that time, one of the two sailors in pair 5 was fit for active duty, and the second had recovered enough to serve as a nurse for the others. None of the other five pairs showed meaningful improvement within the trial period, though the cider pair (pair 1) showed some modest benefit — consistent, we now know, with cider containing small amounts of ascorbic acid.

Source: Lind, J. (1753), A Treatise of the Scurvy, Edinburgh — the original text, Part II, Chapter 3: "A Description of Scurvy Experiments."

The trial was short, the sample was tiny (12 people, six pairs, only two in each group), and Lind himself did not fully grasp the significance of his methodology. But the design was fundamentally sound: same patients, same conditions, same background diet, different treatments applied simultaneously rather than sequentially.

The Structural Innovation: Simultaneous Comparison

The key word is "simultaneously." Most medical thinking before Lind worked by sequential anecdote: a physician tried treatment A, the patient improved, therefore A works. Or a physician saw 20 patients recover with treatment A and concluded it was effective, without recognizing that 17 of those patients might have recovered anyway.

Lind's design — even with its small numbers — eliminated the most common sources of confounding by running all six treatments at the same time, on patients who started in comparable condition, eating the same food. Think of it like testing six different batteries in otherwise identical flashlights at the same time: the only variable is the battery, so a brighter light tells you something real about the battery.

Confounding — in experimental design, a confounding variable is a factor other than the one being tested that could explain the observed outcome. Lind's simultaneous design controlled for confounding by time, by baseline patient condition, and by diet.

This is precisely the logic that modern randomized controlled trials (RCTs) use, scaled to hundreds or thousands of patients. The individual RCT is a direct descendant of the methodology Lind formalized, even if Lind did not name it.

Source: Bhatt, D. L. (2011), "Clinical trials and me: a perspective from the gutter," Journal of the American College of Cardiology, 58(25), 2659–2661 — traces the intellectual genealogy of the RCT to Lind.

Why the Navy Ignored the Finding for 48 Years

Here is the part of the story that is not a triumph: Lind published his findings in 1753. The British Navy did not systematically issue lemon juice to all ships until 1795 — 48 years later.

The delay is not simply a story of institutional inertia. It reflects several genuine complications.

First, lemon juice was expensive and perishable. Preserved lemon juice lost much of its vitamin C content during storage, making the dried or boiled preparations that navies could carry at scale less effective than fresh fruit. When preserved juice was trialed and showed disappointing results, administrators drew the wrong conclusion — that the juice did not work — rather than the correct one, that preservation had destroyed its active component.

Source: Harvie, D. I. (2002), Limeys: The True Story of One Man's War Against Ignorance, the Establishment and the Deadly Scurvy, Sutton Publishing — history of the delay in naval implementation of Lind's findings.

Second, Lind himself undermined his own result. In A Treatise of the Scurvy, he endorsed malt extract as a practical alternative to citrus, partly because malt was cheaper and easier to preserve. Malt contains no significant vitamin C. By recommending an ineffective substitute, Lind inadvertently slowed the adoption of the effective treatment.

Third, the institutional mechanism for translating a surgeon's empirical finding into Navy policy did not exist. Lind had no formal channel for influencing naval provisioning. The bureaucratic path from experimental result to supply chain was long and slow.

The 1795 implementation — triggered by the campaigning of physician Gilbert Blane, who had long advocated for Lind's findings — occurred just in time for the Napoleonic Wars. Scurvy essentially disappeared from the British Navy within years.

Source: Blane, G. (1785), Observations on the Diseases of Seamen, published by the author — Blane's advocacy for citrus, building on Lind's work.

The Active Ingredient Nobody Could Name Until 1932

Lind knew that citrus worked. He did not know why. The scientific explanation took another 185 years.

Vitamin C — ascorbic acid — was isolated and chemically characterized in 1932 by biochemist Albert Szent-Györgyi, working with Hungarian paprika, and independently by Charles Glen King at the University of Pittsburgh.

Ascorbic acid — a water-soluble organic compound (chemical formula C₆H₈O₆) that acts as an antioxidant and is essential for collagen biosynthesis. Humans lack the enzyme L-gulonolactone oxidase, which most other mammals use to synthesize ascorbic acid internally. This makes dietary intake essential.

Source: Szent-Györgyi, A. (1928), "Observations on the function of peroxidase systems and the chemistry of the adrenal cortex," Biochemical Journal, 22, 1387–1409 — the first isolation of what would be identified as vitamin C.

The collagen synthesis pathway is now well characterized: ascorbic acid is required as a cofactor for the enzymes prolyl hydroxylase and lysyl hydroxylase, which add hydroxyl groups to proline and lysine residues in procollagen chains. Without these modifications, procollagen cannot fold correctly into the triple-helix structure of mature collagen. The result is structurally defective connective tissue throughout the body — exactly what scurvy's symptoms describe.

The recommended daily intake of vitamin C to prevent deficiency is 90 mg per day for adult men and 75 mg per day for adult women, according to the WHO. A single medium orange provides roughly 70 mg. One lemon provides roughly 30–40 mg.

Source: WHO (2005), Vitamin and Mineral Requirements in Human Nutrition, 2nd edition — daily requirements for ascorbic acid.

The Lind Trial in the Context of Evidence-Based Medicine

The phrase "evidence-based medicine" was coined in a 1992 paper in the Journal of the American Medical Association by Gordon Guyatt and colleagues at McMaster University. It named a practice that Lind's 1747 experiment had demonstrated in prototype: the idea that clinical decisions should be based on rigorous experimental comparison rather than authority, tradition, or theory.

Source: Evidence-Based Medicine Working Group (1992), "Evidence-based medicine: a new approach to teaching the practice of medicine," JAMA, 268(17), 2420–2425 — coinage of the term and the epistemological case for controlled trials.

Modern randomized controlled trials use random assignment rather than matching, use blinding to prevent observer bias, and operate at statistical scales that make it possible to detect small differences in outcome. But the core logical structure — same conditions, different treatments, simultaneous comparison — is Lind's.

The hierarchy of medical evidence, as used by organizations like the Cochrane Collaboration and the WHO, places well-conducted randomized controlled trials at the top. Systematic reviews of multiple RCTs sit above individual trials. At the bottom sit case reports and expert opinion — the only tools available to medicine before Lind.

Source: Sackett, D. L. et al. (1996), "Evidence based medicine: what it is and what it isn't," BMJ, 312, 71–72 — foundational definition of the evidence hierarchy in modern clinical medicine.

The Timeline

Year	Event
1497	Vasco da Gama's crew suffers severe scurvy on the first sea voyage to India — among the earliest documented shipboard cases
1601	James Lancaster issues lemon juice to one of four ships on an East India Company voyage; that ship has no deaths from scurvy
1720–1740	Multiple competing theories of scurvy circulate in European medical literature — acidity, putrefaction, salt, bad air
1740–1744	Anson's circumnavigation: 1,051 of 1,854 crew die, mostly from scurvy
May 20, 1747	Lind begins his six-pair trial on HMS Salisbury
1748	Lind leaves the Navy, completes a medical degree at Edinburgh
1753	Lind publishes A Treatise of the Scurvy, documenting the 1747 experiment
1758–1794	Lind serves as physician-in-chief at Haslar Naval Hospital
1785	Gilbert Blane publishes Observations on the Diseases of Seamen, advocating for citrus
1794	Lind dies in Gosport, England, aged 78
1795	British Navy officially mandates lemon juice ration for all ships — 48 years after Lind's trial
Mid-19th century	Navy switches from Mediterranean lemons to West Indian limes (lower vitamin C content)
1928	Albert Szent-Györgyi first isolates "hexuronic acid" (later confirmed as vitamin C)
1932	Charles Glen King and Albert Szent-Györgyi independently confirm the isolation and identity of vitamin C as ascorbic acid
1937	Szent-Györgyi awarded Nobel Prize in Physiology or Medicine, partly for vitamin C work
1948	Austin Bradford Hill conducts the streptomycin tuberculosis trial — the first fully randomized controlled clinical trial
1992	"Evidence-based medicine" formally named and defined in JAMA

What Scurvy Does to the Body: The Biochemistry

The 185-year gap between Lind's 1747 experiment and the 1932 isolation of ascorbic acid represents one of the longest delays between a demonstrated clinical effect and its biochemical explanation in the history of medicine.

The collagen connection was not obvious. Collagen is the most abundant protein in the human body, constituting roughly 30% of total protein mass. It provides structural integrity to skin, blood vessel walls, tendons, cartilage, bone, and the tissue that holds healed wounds together. Collagen is not a single molecule but a family of proteins, all sharing a distinctive triple-helix structure: three polypeptide chains wound around each other like a three-strand rope.

Procollagen — the precursor molecule of collagen, synthesized inside cells and then processed into mature collagen fibers before secretion into the extracellular matrix.

The triple-helix structure depends on the hydroxylation of specific proline and lysine residues within the procollagen chains. This hydroxylation — the addition of a hydroxyl (-OH) group — is performed by two enzymes: prolyl-4-hydroxylase and lysyl hydroxylase. Both enzymes require ascorbic acid (vitamin C) as an essential cofactor. Without it, they cannot function.

Source: Peterkofsky, B. (1991), "Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy," American Journal of Clinical Nutrition, 54(6 Suppl), 1135S–1140S — review of ascorbic acid's role in collagen biosynthesis.

When dietary vitamin C drops to near zero, the body can draw on stored ascorbate in tissue for 4 to 12 weeks before clinical deficiency appears. As stores deplete, procollagen hydroxylation fails. Defective procollagen cannot form proper triple helices and is degraded rather than secreted. The result is a progressive failure to maintain connective tissue: blood vessels become fragile, gums deteriorate, old scar tissue breaks down (explaining why healed wounds reopen in scurvy patients), and bones weaken.

The symptoms Lind observed — bleeding gums, reopening wounds, joint pain, extreme weakness — are all direct consequences of collagen failure in specific tissues. The recovery he saw in the citrus-treated pair within six days reflects how quickly the collagen synthesis pathway restores when ascorbate is resupplied.

What Lind Got Wrong

Lind was correct that citrus cured scurvy. He was wrong about why, and he was wrong about what else worked.

His theoretical explanation for why citrus was effective — based on eighteenth-century ideas about acidity and digestion — bore no relationship to the actual mechanism. He also concluded, incorrectly, that malt extract had modest protective properties. The malt recommendation may have slowed adoption of the correct intervention by giving naval administrators a cheaper alternative that did not work.

His published Treatise was also structured more like a literature review with his own trial appended than like a clear experimental report. The 1753 volume dedicates most of its length to summarizing and critiquing previous authors' theories before presenting Lind's own experiment. This structure made his central finding harder to extract and act on.

Source: Milne, I. (2012), James Lind Library — analysis of the structure of the 1753 Treatise and its impact on uptake.

And his sample size was, by modern standards, impossibly small. Twelve patients, two per treatment arm, for six days — this could not distinguish between a treatment that works reliably and one that produces occasional spontaneous recovery. Lind was fortunate that the citrus effect was large enough to be visible despite the tiny numbers.

What People Get Wrong About the Lind Trial

"Lind invented the clinical trial." He demonstrated its logic for the first time in a documented, systematic form. The formal vocabulary of controlled trials — randomization, blinding, statistical power, p-values — was developed in the 20th century. James Lancaster's 1601 lemon juice comparison on a single ship was an uncontrolled precursor. What Lind contributed was the explicit simultaneous comparison under matched conditions, documented in a published work.

"The result proved that vitamin C prevents scurvy." Lind had no concept of vitamins. He demonstrated that citrus fruit cures active scurvy; he could not explain which component of the fruit was responsible, or whether the same component would prevent scurvy if taken before deficiency developed. The extension from "cures" to "prevents" and from "citrus" to "specific molecule" took two more centuries.

"The Navy was simply too stupid or conservative to act on Lind's finding." The delay had defensible reasons. Preserved lemon juice, which was practically what the Navy could carry, genuinely lost vitamin C content during processing and storage. When the Navy trialed preserved citrus products and saw modest results, the finding was ambiguous. The failure was partly a technology problem (how to preserve the active component) as much as an institutional one.

"Lind's experiment was the same as a modern randomized controlled trial." The critical differences are randomization, blinding, and sample size. Lind selected and matched subjects rather than assigning them randomly. Neither he nor the subjects were blinded to treatment allocation. And 12 subjects in six pairs of two gives essentially no statistical power for detecting modest effects. The citrus result was visible only because the effect was large enough to be unmistakable even in a two-person treatment group over six days.

"James Lind is primarily remembered as a great scientist." He is primarily remembered, in medical history, as the person whose finding took 48 years to be implemented — and as a case study in the gap between knowing something works and getting institutions to act on that knowledge. His personal reputation during his lifetime was as a capable and respected naval physician, not as a revolutionary experimenter.

FAQs

Q: Was Lind's trial actually randomized?
A: No. Lind selected and matched his 12 subjects by similarity of condition, not by random assignment. True randomization — which prevents unconscious bias in group allocation — was not formalized as a methodological requirement until the 1920s and 1930s, and was first applied in a major clinical trial by Austin Bradford Hill in the 1948 streptomycin trial for tuberculosis. Lind's design was controlled but not randomized.

Q: Why did sailors call themselves "limeys"?
A: After the Royal Navy adopted lemon juice in 1795, American and other sailors began calling British sailors "limeys" — a reference to the citrus ration. The term is slightly botanically imprecise: the early naval supply used lemons, not limes, which contain less vitamin C per volume. By the mid-19th century, West Indian lime juice replaced Mediterranean lemon juice in the Navy's supply, partly for cost reasons — and since lime has lower vitamin C content, some historians argue this switch actually caused a resurgence of mild scurvy in the later 19th century.

Q: What is the daily requirement for vitamin C?
A: The WHO recommends 45 mg per day as a minimum to prevent deficiency, with higher values (75–90 mg per day) recommended for full antioxidant function. The two oranges and one lemon Lind issued daily would have provided well above the minimum. Symptoms of scurvy typically appear after 4 to 12 weeks of near-zero vitamin C intake, depending on an individual's body stores.

Q: Did Lind know he was running a "controlled trial"?
A: Not in those terms. The vocabulary of experimental design — controls, blinding, randomization, statistical significance — did not exist in 1747. Lind's insight was practical and pragmatic: he knew that sequential anecdotal cases could not answer the question he was asking, so he compared treatments directly. He described his reasoning in the Treatise but did not frame it as a methodological innovation. The recognition of Lind's experiment as the prototype for controlled trials came much later, primarily in the 20th century.

Q: Were there earlier examples of controlled trials before Lind?
A: A few precedents exist in the historical record. The biblical book of Daniel describes a dietary comparison between the Hebrew subjects and Babylonian courtiers, though this is a text, not a verified historical event. A 1601 naval surgeon named James Lancaster issued lemon juice to one ship of a four-ship fleet and tracked differential outcomes — but did not document his design systematically. Lind's experiment is recognized as the first controlled clinical trial because it was the first prospectively designed, documented, and published comparative experiment in medicine.

Q: How long does it take for vitamin C deficiency to produce scurvy symptoms?
A: In adults with adequate prior stores, clinical scurvy typically appears after 4 to 12 weeks of near-total vitamin C deprivation. Early symptoms — fatigue, irritability, joint aching — appear within a month. Gum disease and skin hemorrhages typically follow at 1 to 3 months. Death from untreated scurvy occurs after 3 to 12 months of deficiency, depending on baseline stores and other dietary factors.

The Takeaway

James Lind's experiment on HMS Salisbury produced two results simultaneously. The first was practical: citrus fruit cures scurvy, and navies that issued it stopped losing sailors to the disease. The second was methodological: if you want to know which treatment works, you must test treatments together, on similar patients, under identical conditions. Lind could not name the vitamin he had identified or explain the biochemical pathway it served. But the design of his trial survived both ignorances, because the design was sound regardless of the theory behind it. The controlled clinical trial is how medicine eventually learned to separate what works from what merely sounds plausible — and its first clear instance was a Scottish surgeon on a warship with 12 sick sailors and six different treatments to compare.

---

Read next:

• The Semmelweis Handwashing Experiment
• The Fleming Penicillin Discovery
• The Miller-Urey Experiment